Literature DB >> 24464595

Delayed recognition of Wolfram syndrome frequently misdiagnosed as type 1 diabetes with early chronic complications.

A Zmyslowska1, M Borowiec1, P Fichna2, B Iwaniszewska3, L Majkowska4, I Pietrzak1, M Szalecki5, A Szypowska6, W Mlynarski1.   

Abstract

AIMS: Improvements in diagnostic methods and greater genetic awareness have brought remarkable progress in the recognition of monogenic forms of diabetes, including Wolfram syndrome (WFS). WFS is diagnosed based on clinical criteria of coexistence of diabetes mellitus and optic atrophy, and confirmed by molecular analysis; however, the condition is still sometimes misdiagnosed. To begin to understand the reasons for misdiagnosis, we conducted a retrospective analysis of WFS patients who were originally misdiagnosed.
MATERIALS AND METHODS: The medical histories of 13 pediatric patients with clinical misdiagnosis of type 1 diabetes and early chronic complications made in the years 1995-2010 and who were subsequently correctly diagnosed with WFS based on genetic testing in 2008-2011 were analyzed.
RESULTS: The average age of the patients at diabetes onset was 5 (4.4-6.3) years, and the mean HbA1c level at diagnosis was 9.1±2.3%. Initially, all of these patients were treated as having type 1 diabetes with progressive visual impairment despite good metabolic control (mean HbA1c 7.5±1.3%). Diagnosis of optic atrophy was made at an average age of 9 (5.9-11.5) years, which corresponds to 4 years after diabetes recognition (p=0.002). At the time of genetic analysis, the average age of the patients was 16 (12-18.7) years, which corresponds to 7 years after recognition of coexistence of diabetes mellitus and optic atrophy (p=0.007).
CONCLUSIONS: Delays of at least 7 years occurred before recognition of WFS among a cohort of pediatric patients with diabetes. All patients with WFS were primarily misdiagnosed as having type 1 diabetes. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2014        PMID: 24464595     DOI: 10.1055/s-0033-1357160

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  9 in total

1.  Identification of a missense variant in the WFS1 gene that causes a mild form of Wolfram syndrome and is associated with risk for type 2 diabetes in Ashkenazi Jewish individuals.

Authors:  Vikas Bansal; Bernhard O Boehm; Ariel Darvasi
Journal:  Diabetologia       Date:  2018-07-16       Impact factor: 10.122

2.  [Bilateral optic nerve atrophy in an 18-year-old female patient with diabetes mellitus].

Authors:  Jonathan Hall; Teresa Neuhann; Felix Treumer; Thomas Neuhann; Irmingard Neuhann
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

Review 3.  Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease.

Authors:  Luciana Rigoli; Placido Bramanti; Chiara Di Bella; Filippo De Luca
Journal:  Pediatr Res       Date:  2018-02-28       Impact factor: 3.756

Review 4.  Monogenic Diabetes in Children and Adolescents: Recognition and Treatment Options.

Authors:  May Sanyoura; Louis H Philipson; Rochelle Naylor
Journal:  Curr Diab Rep       Date:  2018-06-22       Impact factor: 4.810

5.  Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome.

Authors:  Agnieszka Zmyslowska; Bogdan Malkowski; Wojciech Fendler; Maciej Borowiec; Karolina Antosik; Piotr Gnys; Dobromila Baranska; Wojciech Mlynarski
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

Review 6.  Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives.

Authors:  Maria Teresa Pallotta; Giorgia Tascini; Roberta Crispoldi; Ciriana Orabona; Giada Mondanelli; Ursula Grohmann; Susanna Esposito
Journal:  J Transl Med       Date:  2019-07-23       Impact factor: 5.531

7.  Retinal thickness as a marker of disease progression in longitudinal observation of patients with Wolfram syndrome.

Authors:  Agnieszka Zmyslowska; Wojciech Fendler; Arleta Waszczykowska; Anna Niwald; Maciej Borowiec; Piotr Jurowski; Wojciech Mlynarski
Journal:  Acta Diabetol       Date:  2017-08-30       Impact factor: 4.280

8.  A novel mutation of WFS1 gene in a Chinese patient with Wolfram syndrome: a case report.

Authors:  Min Li; Jia Liu; Huan Yi; Li Xu; Xiufeng Zhong; Fuhua Peng
Journal:  BMC Pediatr       Date:  2018-03-17       Impact factor: 2.125

Review 9.  Wolfram Syndrome 1: From Genetics to Therapy.

Authors:  Luciana Rigoli; Valerio Caruso; Giuseppina Salzano; Fortunato Lombardo
Journal:  Int J Environ Res Public Health       Date:  2022-03-09       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.